The scientist’s investigation covers issues in Immunology, Platelet-activating factor, Pharmacology, Eosinophil and Platelet. As a part of the same scientific study, B. Boris Vargaftig usually deals with the Immunology, concentrating on Bronchoalveolar lavage and frequently concerns with Methacholine. He usually deals with Platelet-activating factor and limits it to topics linked to Bronchoconstriction and Mepyramine and Prostacyclin.
His study looks at the intersection of Pharmacology and topics like PAF-Acether with Respiratory system. B. Boris Vargaftig interconnects T lymphocyte, Immune system, Interleukin 5, Eosinophilia and Quantitative trait locus in the investigation of issues within Eosinophil. He combines subjects such as Biochemistry and Prostaglandin with his study of Platelet.
Immunology, Pharmacology, Platelet, Internal medicine and Endocrinology are his primary areas of study. His Immunology study deals with Bronchoalveolar lavage intersecting with Methacholine. The concepts of his Pharmacology study are interwoven with issues in Thromboxane, Antagonist, Guinea pig and Platelet-activating factor, PAF-Acether.
The study incorporates disciplines such as Biochemistry and Arachidonic acid in addition to Platelet. His Arachidonic acid research is multidisciplinary, incorporating perspectives in Cyclooxygenase and Prostaglandin. His study in Eosinophil is interdisciplinary in nature, drawing from both Infiltration, Interleukin 5, Eosinophilia, Bronchial hyperresponsiveness and Immunoglobulin E.
His main research concerns Immunology, Inflammation, Endocrinology, Internal medicine and Lung. He combines topics linked to Bronchoalveolar lavage with his work on Immunology. His work on Allergic inflammation as part of general Inflammation research is frequently linked to Mucus, thereby connecting diverse disciplines of science.
The Internal medicine study combines topics in areas such as Ex vivo and Mechanism of action. His Lung study combines topics in areas such as Tumor necrosis factor alpha and Granulocyte. His work investigates the relationship between Anesthesia and topics such as Selective inhibition that intersect with problems in Pharmacology.
B. Boris Vargaftig mainly investigates Immunology, Inflammation, Mucus, Bronchoconstriction and Eosinophil. His work on Histamine expands to the thematically related Immunology. Within one scientific family, B. Boris Vargaftig focuses on topics pertaining to Eosinophilia under Inflammation, and may sometimes address concerns connected to Interleukin 5, Natural killer T cell, Adoptive cell transfer and Interleukin 4.
His research investigates the connection with Bronchoconstriction and areas like Lung which intersect with concerns in Cytokine secretion, Kinase, Bone marrow, Cell and Edema. His research in Eosinophil focuses on subjects like Immunoglobulin E, which are connected to Epitope, Allergy, Leukotriene, BALB/c and Allergen. His Bronchoalveolar lavage study integrates concerns from other disciplines, such as Fibroblast, Interleukin 13 and Methacholine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Perspectives in platelet-activating factor research.
P Braquet;L Touqui;T Y Shen;B B Vargaftig.
Pharmacological Reviews (1987)
Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.
Bernardo B. Vargaftig;Jean Lefort;Michel Chignard;Jacques Benveniste.
European Journal of Pharmacology (1980)
The role of platelet-activating factor in platelet aggregation
M. Chignard;J. P. Le Couedic;M. Tence;B. B. Vargaftig.
Nature (1979)
BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET-ACTIVATING FACTOR (PAF-ACETHER)
B. Boris Vargaftig;Michel Chignard;Jacques Benveniste;Jean Lefort.
Annals of the New York Academy of Sciences (1981)
Cutting Edge: Invariant Vα14 NKT Cells Are Required for Allergen-Induced Airway Inflammation and Hyperreactivity in an Experimental Asthma Model
Mariette Lisbonne;Séverine Diem;Alexandre de Castro Keller;Alexandre de Castro Keller;Jean Lefort.
Journal of Immunology (2003)
Present concepts on the mechanisms of platelet aggregation
B.B. Vargaftig;M. Chignard;J. Benveniste.
Biochemical Pharmacology (1981)
Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice.
C Zuany-Amorim;S Hailé;D Leduc;C Dumarey.
Journal of Clinical Investigation (1995)
Requirement for γδ T Cells in Allergic Airway Inflammation
Claudia Zuany-Amorim;Claude Ruffié;Solomon Hailé;B. Boris Vargaftig.
Science (1998)
Platelet activation—a role for a 40K anti-phospholipase A2 protein indistinguishable from lipocortin
Lhousseine Touqui;Bernard Rothhut;Angus M. Shaw;Armel Fradin.
Nature (1986)
Murine models of asthma
Johan C. Kips;G. P. Anderson;J. J. Fredberg;U. Herz.
European Respiratory Journal (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
Inserm : Institut national de la santé et de la recherche médicale
Oswaldo Cruz Foundation
University of Orléans
Institut Pasteur
Institut Pasteur
Universidade de São Paulo
Oswaldo Cruz Foundation
Universidade de São Paulo
University of Orléans
Grenoble Alpes University
Lund University
Dalhousie University
International Maize and Wheat Improvement Center
KU Leuven
Tokyo Medical and Dental University
Northwestern University
University of Copenhagen
French Research Institute for Exploitation of the Sea
Langley Research Center
University of Queensland
Stanford University
University of Bergen
Plymouth University
Northwestern University
Johns Hopkins University